4/30/2013

India's health ministry has announced a new policy halting the sale of any drugs banned by the European Union, U.S., U.K., Canada, Japan or Australia. Such sales will be stopped until clinical trials inside India determine that the drugs have no adverse effects on patients. A parliamentary probe last year found that India continued to permit the sale of Analgin, a painkiller banned in Sweden and the U.S., after it was found to trigger a steep decline in white blood cell counts.

Related Summaries